Darwin Global Management, Ltd. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001839209

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q4 2023 · 8 positions · Total reported value $509.48M · Top-10 concentration 100.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 50.0% · 0 new · 2 cut · 1 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): -16.0% · vs SPY -30.8% · Prev Value $3.77B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2023 13F filing, Darwin Global Management, Ltd. disclosed 8 equity positions with a combined reported value of $509.48M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2023 were AMAM ($237.65M), TGTX ($69.12M), MLTX ($62.76M). By sector, the heaviest allocations are Health Care 51.1%, Other 48.9%. Versus the prior quarter, allocation shifted toward Health Care (+18.7pp) and away from Other (-18.7pp).

Versus the prior quarter, Darwin Global Management, Ltd. opened 0 new positions, trimmed 2 and fully exited 1, a turnover rate of 50.0% of positions. The portfolio's overlap with the prior quarter was 10% of names.

The largest new positions opened in Q4 2023 were TGTX ($69.12M), MLTX ($62.76M), CYTK ($50.09M).

Of the 1 positions fully exited versus the prior quarter, the largest were IMVT ($69.81M), ARGX ($22.43M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2023)

  • TGTX TG THERAPEUTICS INC · $69.12M
  • MLTX MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD · $62.76M
  • CYTK CYTOKINETICS INC · $50.09M
  • KROS KEROS THERAPEUTICS INC · $42.16M
  • PCVX VAXCYTE INC · $36.42M
  • SWTX SPRINGWORKS THERAPEUTICS INC · $7.03M
  • NUVL NUVALENT INC · $4.25M

Fully Exited (vs previous quarter)

  • IMVT IMMUNOVANT INC · prev qtr: $69.81M
  • ARGX ARGENX SE · prev qtr: $22.43M

Insider Transactions (Form 4)

Latest Darwin Global Management, Ltd. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Darwin Global Management, Ltd. is an SEC-registered 13F filer. As of Q2 2026 it reported 5 US equity positions with a combined value of $3.76B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 5 positions · $3.76B reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: RVMD (REVOLUTION MEDICINES INC) at 54.5%
  • Average position size: $752.05M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 3 added, 2 reduced, 1 exited

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 51.1%
Other 48.9%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 16.69M $237.65M 46.65%
46.65%
Hold
2 4.05M $69.12M 13.57%
13.57%
New
3 1.04M $62.76M 12.32%
12.32%
New
4 600.00K $50.09M 9.83%
9.83%
New
5 1.06M $42.16M 8.28%
8.28%
New
6 579.96K $36.42M 7.15%
7.15%
New
7 192.73K $7.03M 1.38%
1.38%
New
8 57.70K $4.25M 0.83%
0.83%
New

FAQ

What did Darwin Global Management, Ltd. buy in 2023-Q4?

In its 2023-Q4 13F filing, Darwin Global Management, Ltd. reported 8 equity positions worth $509.48M in aggregate; its largest disclosed positions were AMAM ($237.65M), TGTX ($69.12M), MLTX ($62.76M).

How large is Darwin Global Management, Ltd.'s portfolio?

Darwin Global Management, Ltd. reported $509.48M of long equity holdings across 8 positions as of 2023-Q4. Top-10 holdings account for 100.0% of reported value.

What is Darwin Global Management, Ltd.'s investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/darwin-global-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →